This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Types

Authoring team

Inactive IUCD's are small objects made of polyethylene or nylon. They are thought to inhibit the implantation of the blastocyst by causing chronic irritation of the endometrium. In the absence of symptoms, they may be left indefinitely.

Active IUCD's contain metals or hormones and have largely superseded the passive devices as they tend to be smaller and have lower failure rates.

Copper is commonly used e.g. Copper-7. It is believed to inhibit enzymes present in the endometrium required for implantation. There is no significant absorption systemically and there is no danger from teratogenicity in the case of accidental pregnancy. The copper is slowly lost by elution. Newer devices need replacing every for 4 - 6 years.

The intra-uterine progestogen-only contraceptive releases levonorgestrel directly in to the uterine cavity. This device has a lower incidence of ectopic pregnancy than copper IUCDs and has a failure rate similar to that given by sterilisation.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.